Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
Status:
Unknown status
Trial end date:
2020-07-10
Target enrollment:
Participant gender:
Summary
This study is conducted to evaluate efficacy and safety of neoadjuvant chemotherapy followed
by preoperative chemoradiotherapy in patients with resectable esophageal squamous cell
carcinoma